Laparoscopic Treatment of Zinner Syndrome: A Case Report.

Am J Case RepSep 30, 2026 (epub)
Case ReportUrologyGeneral SurgeryPathology (Anatomic & Clinical)

Kuandyk Beisenov, Yuriy Pak, Zhalgas Igembay et al.

✦ AI-curated · Sources linked

Case in brief

A 36-year-old man presented with infertility and chronic pelvic pain, diagnosed with Zinner syndrome, which included left renal agenesis, ureteral atresia, and a large seminal vesicle cyst. He underwent laparoscopic excision of the cyst, which contained approximately 120 mL of fluid. Postoperatively, he experienced complete pain resolution and improved semen parameters, indicating partial recovery of ejaculatory function.

Diagnostic / clinical pearl

Clinicians should consider Zinner syndrome in patients with unilateral renal agenesis and pelvic pain, as timely diagnosis can lead to effective laparoscopic treatment.

Why it matters

This case underscores the potential for laparoscopic surgery to alleviate symptoms and improve fertility outcomes in patients with Zinner syndrome.

Source

PubMed · PMID 42811540

Published in Am J Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Urology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.